These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6959488)

  • 1. Clinical symptomatology, CSF neurotransmitter metabolites, and serum haloperidol levels in Tourette syndrome.
    Singer HS; Tune LE; Butler IJ; Zaczek R; Coyle JT
    Adv Neurol; 1982; 35():177-83. PubMed ID: 6959488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic dsyfunction in Tourette syndrome.
    Singer HS; Butler IJ; Tune LE; Seifert WE; Coyle JT
    Ann Neurol; 1982 Oct; 12(4):361-6. PubMed ID: 6184010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of clinical pictures and monoamine metabolism of Gilles de la Tourette syndrome].
    Takano K; Ishiguro T
    Seishin Shinkeigaku Zasshi; 1993; 95(1):1-29. PubMed ID: 7685527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in Gilles de la Tourette syndrome: implications for clinical practice and future research.
    Leckman JF; Cohen DJ
    Psychiatr Dev; 1983; 1(3):301-16. PubMed ID: 6324164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum haloperidol levels in Gilles de la Tourette syndrome.
    Singer HS; Rabins P; Tune LE; Coyle JT
    Biol Psychiatry; 1981 Jan; 16(1):79-84. PubMed ID: 6939449
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebrospinal fluid monoamine metabolites in Tourette syndrome and their neuroendocrine implications.
    Koslow SH; Cross CK
    Adv Neurol; 1982; 35():185-97. PubMed ID: 6959489
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome.
    Steeves TD; Fox SH
    Prog Brain Res; 2008; 172():495-513. PubMed ID: 18772048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
    Haleem DJ; Batool F; Khan NH; Kamil N; Ali O; Saify ZS; Haleem MA
    Med Sci Monit; 2002 Sep; 8(9):BR354-61. PubMed ID: 12218936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics, haloperidol and pimozide: a comparative study in two mouse strains.
    Messiha FS
    Neurotoxicology; 1991; 12(1):47-54. PubMed ID: 2014068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of haloperidol in high doses in schizophrenia. Clinical, biochemical and pharmacokinetic study].
    Scatton B; Zarifian E; Bianchetti G; Cuche H; Loo H; Morselli PL
    Encephale; 1982; 8(1):1-8. PubMed ID: 7094868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Features of the temporal structure of the respiratory cycle in the Tourette syndrome as a possible reflection of intensified dopaminergic processes].
    Shchelkunov EL; Kenunen OG; Voronov IB; Zimin AL; Kharitonov RA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(10):1500-5. PubMed ID: 3000115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating Tourette syndrome with haloperidol: predictors of success.
    Schwabe MJ; Konkol RJ
    Wis Med J; 1989 Oct; 88(10):23-7. PubMed ID: 2815810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tourette syndrome. Genetics, neuroanatomy and neurotransmitters].
    Debes NM; Skov L; Hjalgrim H
    Ugeskr Laeger; 2008 Aug; 170(35):2695-700. PubMed ID: 18761860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of pharmacological approaches to therapy for Tourette syndrome.
    van Woert MH; Rosenbaum D; Enna SJ
    Adv Neurol; 1982; 35():369-75. PubMed ID: 6183950
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs.
    Henderson MG; McMillen BA
    Teratology; 1993 Nov; 48(5):421-30. PubMed ID: 7508151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep in Gilles de la Tourette syndrome.
    Mendelson WB; Caine ED; Goyer P; Ebert M; Gillin JC
    Biol Psychiatry; 1980 Apr; 15(2):339-43. PubMed ID: 6932227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Chinese herbal medicine Ningdong granule on regulating dopamine (DA)/serotonin (5-TH) and gamma-amino butyric acid (GABA) in patients with Tourette syndrome.
    Wang S; Qi F; Li J; Zhao L; Li A
    Biosci Trends; 2012 Aug; 6(4):212-8. PubMed ID: 23006968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of haloperidol in young Tourette syndrome patients.
    Bogomolny A; Erenberg G; Rothner AD
    Adv Neurol; 1982; 35():427-32. PubMed ID: 6959520
    [No Abstract]   [Full Text] [Related]  

  • 19. Decreased serotoninergic activity in Tourette syndrome.
    Crosley CJ
    Ann Neurol; 1979 Jun; 5(6):596-7. PubMed ID: 289336
    [No Abstract]   [Full Text] [Related]  

  • 20. Tics and Tourette syndrome.
    Singer HS
    Johns Hopkins Med J; 1982 Jul; 151(1):30-5. PubMed ID: 6953280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.